Study details the unprecedented scale, diversity, and power of the All of Us Research Program Researchers have discovered more than 275 million previously unreported genetic variants, identified from data shared by...read more
Category - Industry trends
TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.
Contact me to get the spreadsheet with full data I used for my analysis. As a CEO of an early-stage biotech company (Neurolentech) operating in the spaceof neurodevelopmental diseases (NDDs), I spend a significant part...read more
The FDA’s Center for Drug Evaluation and Research (CDER) Approved 55 New Drugs in 2023
The Small Molecule and Biologic Pharmacopoeia Continues to Grow This cohort is nearly 50% bigger than the new approval class of 2022 (see Figure 1). Figure 1: 30 years of novel FDA approvals. Annual numbers of...read more
2023 Watch List: Top 10 Precision Medicine Technologies and Issues
CADTH routinely identifies new and emerging technologies that are likely to have a significant and meaningful impact on Canada’s health care systems. CADTH’s annual watch lists specifically identify technologies that...read more
